FDA Approved: FORMOTEROL FUMARATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Formoterol Fumarate submitted by Mylan Pharmaceuticals, resulting in a change to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• FORMOTEROL FUMARATE (Formoterol fumarate dihydrate)

Snippet

SUPPL AP for FORMOTEROL FUMARATE (FORMOTEROL FUMARATE DIHYDRATE)